2638 - DCGI approves Bharat Biotech's Covaxin for kids aged 12-18 years

The DCGI has approved Bharat Biotech’s Covaxin COVID-19 vaccine for emergency use among children aged 12 to 18 years. Covaxin will be administered among children in two doses, with a gap of 28 days between the first and second dose. In October, the Subject Expert Committee (SEC) had recommended the DCGI to allow emergency use of Covaxin among children.